Literature DB >> 19481838

[Should we change our attitude on postmenopausal hormone replacement therapy?].

Alberto López García-Franco, Pablo Alonso Coello, Isabel del Cura González, Julia Ojuel Solsona, Lorenzo Arribas Mir, Mercè Fuentes Pujol, Emilia Bailón Muñoz, Blanca Gutierrez Teira, María José Iglesias Piñeiro, Jacinta Landa Goñi.   

Abstract

Mesh：

Year:  2009        PMID： 19481838      PMCID： PMC7021939          DOI： 10.1016/j.aprim.2009.03.007

Source DB:  PubMed          Journal:  Aten Primaria        ISSN： 0212-6567            Impact factor:   1.137


× No keyword cloud information.
  13 in total

1.  Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk.

Authors:  C Schairer; J Lubin; R Troisi; S Sturgeon; L Brinton; R Hoover
Journal:  JAMA       Date:  2000-01-26       Impact factor: 56.272

Review 2.  Hormone therapy to prevent disease and prolong life in postmenopausal women.

Authors:  D Grady; S M Rubin; D B Petitti; C S Fox; D Black; B Ettinger; V L Ernster; S R Cummings
Journal:  Ann Intern Med       Date:  1992-12-15       Impact factor: 25.391

3.  Drugs for pre-osteoporosis: prevention or disease mongering?

Authors:  Pablo Alonso-Coello; Alberto López García-Franco; Gordon Guyatt; Ray Moynihan
Journal:  BMJ       Date:  2008-01-19

4.  Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women.

Authors:  Elizabeth Barrett-Connor; Lori Mosca; Peter Collins; Mary Jane Geiger; Deborah Grady; Marcel Kornitzer; Michelle A McNabb; Nanette K Wenger
Journal:  N Engl J Med       Date:  2006-07-13       Impact factor: 91.245

5.  Raloxifene and cardiovascular events in osteoporotic postmenopausal women: four-year results from the MORE (Multiple Outcomes of Raloxifene Evaluation) randomized trial.

Authors:  Elizabeth Barrett-Connor; Deborah Grady; Andreas Sashegyi; Pamela W Anderson; David A Cox; Krzysztof Hoszowski; Pentti Rautaharju; Kristine D Harper
Journal:  JAMA       Date:  2002-02-20       Impact factor: 56.272

6.  Effect of postmenopausal hormone therapy on lipoprotein(a) concentration. PEPI Investigators. Postmenopausal Estrogen/Progestin Interventions.

Authors:  M A Espeland; S M Marcovina; V Miller; P D Wood; C Wasilauskas; R Sherwin; H Schrott; T L Bush
Journal:  Circulation       Date:  1998-03-17       Impact factor: 29.690

7.  Recency and duration of postmenopausal hormone therapy: effects on bone mineral density and fracture risk in the National Osteoporosis Risk Assessment (NORA) study.

Authors:  Elizabeth Barrett-Connor; Lois E Wehren; Ethel S Siris; Paul Miller; Ya-Ting Chen; Thomas A Abbott; Marc L Berger; Arthur C Santora; Louis M Sherwood
Journal:  Menopause       Date:  2003 Sep-Oct       Impact factor: 2.953

8.  Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial.

Authors:  Sally A Shumaker; Claudine Legault; Stephen R Rapp; Leon Thal; Robert B Wallace; Judith K Ockene; Susan L Hendrix; Beverly N Jones; Annlouise R Assaf; Rebecca D Jackson; Jane Morley Kotchen; Sylvia Wassertheil-Smoller; Jean Wactawski-Wende
Journal:  JAMA       Date:  2003-05-28       Impact factor: 56.272

9.  Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study.

Authors:  Sally A Shumaker; Claudine Legault; Lewis Kuller; Stephen R Rapp; Leon Thal; Dorothy S Lane; Howard Fillit; Marcia L Stefanick; Susan L Hendrix; Cora E Lewis; Kamal Masaki; Laura H Coker
Journal:  JAMA       Date:  2004-06-23       Impact factor: 56.272

10.  Main morbidities recorded in the women's international study of long duration oestrogen after menopause (WISDOM): a randomised controlled trial of hormone replacement therapy in postmenopausal women.

Authors:  Madge R Vickers; Alastair H MacLennan; Beverley Lawton; Deborah Ford; Jeannett Martin; Sarah K Meredith; Bianca L DeStavola; Sally Rose; Anthony Dowell; Helen C Wilkes; Janet H Darbyshire; Tom W Meade
Journal:  BMJ       Date:  2007-07-11
View more
  1 in total

1. 

Authors:  Alberto López García-Franco; José Antonio Baeyens Fernández; Emilia Bailón Muñoz; M José Iglesias Piñeiro; Isabel Del Cura González; Amparo Ortega Del Moral; Jacinta Landa Goñi; Pablo Alonso Coello; Lorenzo Arribas Mir
Journal:  Aten Primaria       Date:  2018-05       Impact factor: 1.137
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.